Skip to content
value.today

NanoCellect Biomedical, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2011

Formerly NanoSort, Inc.

Total raised
$58 M
4 rounds on record
Latest round
$29 M
Jun 2023
First round on record
Oct 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NanoCellect Biomedical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2023$29 MNo. 4$10 to $50 million

NanoCellect Biomedical, Inc.: Raise no. 4, Jun 2023

Investors in this round

32 investors had bought by the notice of Jun 30, 2023: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $39 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Neary · Executive Officer, Director
  • Jeremy Baker · Executive Officer
  • Jose Morachis · Executive Officer
  • Nicolas Barthelemy · Director
  • Paul Conley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes Convertible Promissory Notes convertible into shares of Series AA-2 Pref of Issuer. Total Offering Amount includes amount receivable by Issuer upon exercise of a warrant to purchase Issuer's Series Junior Pref. The warrant has not been exercised.”

Signed by Chris Neary, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 30, 2023. Read the notice at the SEC.

equity, optionsSEC
Aug 2021$20 MNo. 3$10 to $50 million

NanoCellect Biomedical, Inc.: Raise no. 3, Aug 2021

Investors in this round

15 investors had bought by the notice of Aug 27, 2021: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Neary · Executive Officer, Director
  • Jeremy Baker · Executive Officer
  • Jose Morachis · Executive Officer, Director
  • Alexis Ji · Director
  • Jack Ball · Director
  • Kenneth Hood · Director
  • Nicolas Barthelemy · Director
  • Paul Conley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Neary, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 27, 2021. Read the notice at the SEC.

equitySEC
Nov 2017$7 MNo. 2$2 to $10 million

NanoCellect Biomedical, Inc.: Raise no. 2, Nov 2017

Investors in this round

11 investors had bought by the notice of Dec 5, 2017: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jose Morachis · Executive Officer, Director
  • Nate Heintzman · Executive Officer
  • William Alaynick · Executive Officer, Director
  • Alexis Ji · Director
  • Jack Ball · Director
  • Kenneth Hood · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jose Morachis, President and CEO. Source: SEC Form D, newest notice filed Dec 5, 2017. Read the notice at the SEC.

equitySEC
Oct 2015$2 MNo. 1Under $2 million

NanoCellect Biomedical, Inc.: Raise no. 1, Oct 2015

Investors in this round

3 investors had bought by the notice of Jan 22, 2016: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jose Morachis · Executive Officer, Director
  • Nate Heintzman · Executive Officer, Director
  • William Alaynick · Executive Officer, Director
  • Kenneth Hood · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jose Morachis, President and CEO. Source: SEC Form D, newest notice filed Jan 22, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NanoCellect Biomedical, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2023).

    SEC Form D · Jun 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2023

That is all the official record says: NanoCellect Biomedical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NanoCellect Biomedical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 32 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NanoCellect Biomedical, Inc.
NameRoleNamed in
Chris NearyExecutive officerJun 2023
Jeremy BakerExecutive officerJun 2023
Jose MorachisExecutive officerJun 2023
Nate HeintzmanExecutive officerDec 2017
William AlaynickExecutive officerDec 2017
Chris NearyDirectorJun 2023
Nicolas BarthelemyDirectorJun 2023
Paul ConleyDirectorJun 2023
Alexis JiDirectorAug 2021
Jack BallDirectorAug 2021
Jose MorachisDirectorAug 2021
Kenneth HoodDirectorAug 2021
William AlaynickDirectorDec 2017
Nate HeintzmanDirectorJan 2016